Wei Chou Tseng
About Wei Chou Tseng
Wei Chou Tseng is a Senior Scientist II at Wave Life Sciences, where he has worked since 2020. He has extensive experience in pharmacology and toxicology, having previously held positions at Pfizer, Q-State Biosciences, and Duke University.
Current Role at Wave Life Sciences
Wei Chou Tseng serves as a Senior Scientist II at Wave Life Sciences, a position he has held since 2020. In this role, he collaborates with various teams, including manufacturing, data science, and development, as well as Contract Research Organizations (CROs), to ensure effective organization of work. He is involved in designing preclinical studies, which encompass routine toxicology readouts and non-human primate pilot pharmacokinetics and pharmacodynamics (PK/PD) studies.
Previous Experience at Pfizer
Prior to his current position, Wei Chou Tseng worked at Pfizer as a Postdoctoral Fellow from 2014 to 2018 in the Greater Boston Area. During his tenure, he contributed to proof-of-concept studies aimed at enhancing the understanding of molecular and cellular mechanisms that support ongoing clinical trials. His work involved collaboration with various research teams to advance therapeutic development.
Academic Background
Wei Chou Tseng earned his Bachelor of Science (B.S.) in Biochemistry and Molecular Biology from National Taiwan University, where he studied from 2003 to 2007. He furthered his education at Duke University, obtaining a Doctor of Philosophy (Ph.D.) in Pharmacology and Toxicology between 2007 and 2014. His academic training laid the foundation for his research and scientific contributions in the field.
Research and Development Contributions
Throughout his career, Wei Chou Tseng has focused on the development of antisense oligonucleotides (ASOs) as therapeutic agents. He has designed and executed in vitro experiments to assess ASO knockdown potency in induced pluripotent stem cell (iPSC)-derived cellular models. His expertise includes characterizing the pharmacokinetics (PK) and pharmacodynamics (PD) of ASOs in in vivo mouse models, contributing to the advancement of therapeutic applications.
Leadership and Training Experience
Wei Chou Tseng has taken on leadership roles, managing teams of scientists and research associates for multiple preclinical and clinical programs. He has also been involved in training and developing scientists and research associates across various departments, enhancing the capabilities of his teams and fostering a collaborative research environment.